Celldex Therapeutics CLDX Intangibles (Net)
Intangibles (Net) at other companies
Other financials
Where this comes from
Reported directly by Celldex Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.
The official record: Celldex Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Celldex Therapeutics's intangibles (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Celldex Therapeutics's intangibles (net)?
- Celldex Therapeutics (CLDX) reported intangibles (net) of $27.19M in Q1 2026.
- How has Celldex Therapeutics's intangibles (net) changed year-over-year?
- Celldex Therapeutics's intangibles (net) decreased by 0.0% year-over-year, from $27.19M to $27.19M.
- What is the long-term trend for Celldex Therapeutics's intangibles (net)?
- Over 5 years (2020 to 2025), Celldex Therapeutics's intangibles (net) has grown at a -2.4% compound annual growth rate (CAGR), from $30.69M to $27.19M.
- What does intangibles (net) mean?
- Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.